Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients
- 1 January 1992
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 31 (3) , 251-254
- https://doi.org/10.1007/bf00685556
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pharmacokinetics of Rectal Drug Administration, Part IClinical Pharmacokinetics, 1991
- Morphine-3-glucuronide - a potent antagonist of morphine analgesiaLife Sciences, 1990
- Mean Time Parameters in PharmacokineticsClinical Pharmacokinetics, 1989
- The rectal administration of MS Contin®: Clinical implications of use in end stage cancerAmerican Journal of Hospice Care, 1989
- Bioavailability of morphine from suppositoriesInternational Journal of Pharmaceutics, 1988
- ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDEThe Lancet, 1988
- The Bioavailability of Rectally Administered MorphineBasic & Clinical Pharmacology & Toxicology, 1988
- Management of Cancer Pain With Oral Controlled‐Release Morphine SulfateThe Journal of Clinical Pharmacology, 1987
- The reliability of a linear analogue for evaluating painAnaesthesia, 1976
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976